SHEA expertise is routinely sought by regulatory and legislative entities. This section showcases public comments and policy communications.

Sample Report icon
Abstract:

SHEA submitted comments to FDA on its Guidance for industry regarding enforcement policy for use of FMT to treat Clostridium difficile infection not responsive to standard therapies.

View PDF (395 KB)

Sample Report icon
Abstract:

SHEA and IDSA submitted a joint letter to CMS on March 4 advancing Antimicrobial Stewardship as a Condition of Participation.

View PDF (724 KB)